ReviewCureus2025
Supraspinal Mechanisms of Spinal Cord Stimulation in Pain Mitigation: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Molecular and Cellular Mechanisms of Spinal Cord Stimulation: Linking Dorsal Horn Circuits, Glia, and ECAP-Guided Therapy.International journal of molecular sciences · 2026Review
- Review
- Comparative Efficacy of Pulsed Radiofrequency-Based and Related Interventions for Postherpetic Neuralgia: A Network Meta-Analysis of Randomized Controlled Trials.Journal of pain research · 2026Review
- Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord stimulation (SCS) has been established as an effective intervention for chronic pain syndromes, including persistent spinal pain syndrome type 2 (PSPS-T2) and complex regional pain syndrome (CRPS). Nevertheless, the underlying mechanisms responsible for SCS-induced analgesia remain incompletely understood, particularly regarding the supraspinal pathways, which have not been sufficiently clarified. A systematic review was conducted to aggregate evidence concerning the supraspinal influences of SCS on pain modulation. Following an extensive literature search facilitated by a professional librarian and adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a thorough selection process was executed. Animal studies that investigated the supraspinal circuitry implicated in SCS-induced analgesia were incorporated into the review. Conversely, studies that solely examined spinal effects or lacked appropriate experimental controls were excluded from consideration. Ultimately, four studies fulfilled the inclusion criteria. Collectively, these investigations revealed direct anatomical projections from the dorsal column nuclei (DCN) to the periaqueductal gray (PAG), a reduction in extracellular gamma-aminobutyric acid (GABA) levels within the PAG following SCS, which facilitates disinhibition of descending pain pathways, and heightened activity of OFF-like and serotonergic neurons in the rostral ventromedial medulla (RVM), thereby contributing to antinociceptive outcomes. SCS engages a network of supraspinal structures, particularly the DCN-PAG-RVM axis, to mediate analgesia via neurotransmitter modulation and descending inhibitory mechanisms. These results underscore a complex supraspinal contribution to the efficacy of SCS and advocate for future investigations into optimized neuromodulation protocols that target brainstem circuitry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.